Tech Center 1600 • Art Units: 1618
This examiner grants 63% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17302143 | METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION | Final Rejection | The University of Chicago |
| 16458614 | Carrier Nanoparticles And Related Compositions, Methods And Systems | Final Rejection | California Institute Of Technology |
| 17863066 | HYBRID NANOPARTICLES COMPRISING MANGANESE OXIDE AND HIGHLY REDUCED GRAPHENE OXIDE FOR THERANOSTIC APPLICATIONS | Non-Final OA | King Saud University |
| 17827479 | BRANCHED DISCRETE PEG CONSTRUCTS | Non-Final OA | UNIVERSITY OF WASHINGTON |
| 17769892 | TARGET DELIVERY OF NON-BIOLOGICS THROUGH NANOTECHNOLOGY FOR TISSUE REPAIR | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 18349851 | FLUORESCENT COMPOUND COMPRISING A FLUOROPHORE CONJUGATED TO A pH-TRIGGERED POLYPEPTIDE | Non-Final OA | YALE UNIVERSITY |
| 17825217 | System, Emanation Generator, and Process for Production of High-Purity Therapeutic Radioisotopes | Final Rejection | BATTELLE MEMORIAL INSTITUTE |
| 18402910 | INHIBITORS OF THE IRE-1/XBP-1 PATHWAY AND METHODS OF USING THEREOF | Final Rejection | H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. |
| 17749902 | MESOSCALE NANOPARTICLES FOR SELECTIVE TARGETING TO THE KIDNEY AND METHODS OF THEIR THERAPEUTIC USE | Non-Final OA | Research Foundation of the City University of New York |
| 16707423 | Functionalized Polyvinyl Alcohol and Products Formed Therewith | Final Rejection | UNIVERSITY OF SOUTH CAROLINA |
| 18654606 | NANOPARTICLES COMPRISING PEPTIDES INCLUDING AN N-TERMINAL LINKER | Non-Final OA | Topas Therapeutics GmbH |
| 17440067 | PEPTIDE-INDUCED NK CELL ACTIVATION | Non-Final OA | University of Southampton |
| 18647137 | STEM CELL DERIVED PANCREATIC ISLET DIFFERENTIATION | Non-Final OA | Vertex Pharmaceuticals Incorporated |
| 18530122 | LIPOSOMAL NANOCARRIER DELIVERY SYSTEM FOR TARGETING ACTIVE CD44 MOLECULE,PREPARATION METHOD THEREFOR, AND USES THEREOF | Non-Final OA | Beijing Inno Medicine Co., Ltd. |
| 18434315 | NANOPARTICLES PRE-FUNCTIONALISED USING A SELF-ASSEMBLED MONOLAYER AND METHOD FOR PREPARING SAME | Non-Final OA | Ecole Normale Supérieure Paris-Saclay |
| 17962198 | LIGHT-EMITTING NANOPARTICLES, CELL DETECTION METHOD USING SAME, ANIMAL TREATMENT METHOD, MEDICAL DEVICE, CELL VISUALIZATION METHOD, AND METHOD FOR REDUCING INJURY TO CELL | Final Rejection | National Institute of Technology |
| 16089758 | LIGHT-EMITTING NANOPARTICLES, CELL DETECTION METHOD USING SAME, ANIMAL TREATMENT METHOD, MEDICAL DEVICE, CELL VISUALIZATION METHOD, AND METHOD FOR REDUCING INJURY TO CELL | Final Rejection | National Institute of Technology |
| 17610892 | SENSORS AND METHODS USING ELECTROCHEMILUMINESCENCE OF METAL NANOCLUSTERS | Non-Final OA | Georgia State University Research Foundation, Inc. |
| 18270118 | IRON OXIDE MAGNETIC PARTICLES | Non-Final OA | ZTI BIOSCIENCES CO., LTD. |
| 18269585 | IRON OXIDE MAGNETIC PARTICLES | Non-Final OA | ZTI BIOSCIENCES CO.,LTD. |
| 17782940 | METHODS, SYSTEMS, AND COMPOSITIONS FOR ACHIEVING A HEALTHY INTRAOCULAR PRESSURE FOLLOWING COMBINED GLAUCOMA FILTRATION SURGERY AND CATARACT EXTRACTION | Non-Final OA | RADIANCE THERAPEUTICS, INC. |
| 17757786 | uPAR-TARGETED PHOTOTHERMAL OPTICAL PROBES FOR PHOTOTHERMAL THERAPY | Final Rejection | RIGSHOSPITALET |
| 18255607 | MARKER FOR USE IN IDENTIFYING OR PREDICTING ANGIOGENESIS | Non-Final OA | NOVAI LTD |
| 17613580 | ANTI-GLYPICAN-3 ANTIBODIES AND USES THEREOF | Non-Final OA | Memorial Sloan Kettering Cancer Center |
| 17791028 | COMPANION DIAGNOSIS BIOMARKER COMPOSITION AND COMPANION DIAGNOSIS KIT CONTAINING SAME | Non-Final OA | INNOBATION BIO CO., LTD. |
| 17773485 | DESIGN AND CHARACTERIZATION OF MULTILAYERED STRUCTURES FOR SUPPORT OF LIPID BILAYERS | Non-Final OA | THE TRUSTEES OF WHEATON COLLEGE |
| 16346920 | RADIOPAQUE POLYMERS WITH ENHANCED RADIOPACITY | Non-Final OA | ENDOSHAPE, INC. |
| 17413517 | METHOD OF PRODUCING POLY(ALKYL CYANOACRYLATE) BASED NANO/MICROFIBERS AND USES THEREOF | Final Rejection | WIWEX GmbH |
| 17229013 | Gold-Based Nanocrystals for Medical Treatments and Electrochemical Manufacturing Processes Therefor | Final Rejection | KENSINGTON CLENE 2024 LLC |
| 17223336 | NOVEL GOLD-BASED NANOCRYSTALS FOR MEDICAL TREATMENTS AND ELECTROCHEMICAL MANUFACTURING PROCESSES THEREFOR | Non-Final OA | KENSINGTON CLENE 2024 LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy